Musculoskeletal manifestations of Fabry disease: A retrospective study.

作者: Olivier Lidove , Valérie Zeller , Valérie Chicheportiche , Vanina Meyssonnier , Thomas Sené

DOI: 10.1016/J.JBSPIN.2015.11.001

关键词:

摘要: Abstract Objectives Fabry disease is a rare X-linked metabolic disorder characterized by deficiency in the enzyme alpha-galactosidase A. Both males and females can be affected. The main presenting symptom pain extremities, whereas at more advanced stage, manifestations include hypertrophic cardiomyopathy, cardiac dysrhythmia, proteinuria, chronic kidney dysfunction, stroke, hearing loss. When not diagnosed treated, causes early death. No studies specifically designed to describe musculoskeletal of are available. Methods We conducted single-center retrospective study patients receiving follow-up referral center. described analyzed differential diagnoses. Results Our included 40 belonging 20 families, including 25 with mean age 44.2 years (range, 20–76 years) 15 40.1 16–61 years). Mean diagnosis was 37.2 7–71 26.9 9–51 males. Specific replacement therapy given 10 (40%) 12 (80%) Musculoskeletal were as follows: past or present extremities (13 males), combined some vasomotor disorders telangiectasia; exercise intolerance (12 males); osteoporotic fractures (2 brothers aged 45 44 years, respectively); osteoporosis (3 females, 57, 63, 75 respectively), which contributed death oldest patient; osteopenia (2 38 47 respectively; 1 male 43 years); Charcot foot lymphedema serious infectious complications (4 older than years), avascular osteonecrosis lower limbs 2 cases; toe amputations cases); bilateral lower-limb amputation (1 case); abnormally slender (5 8 acute gout severe failure); carpal tunnel syndrome female male, both younger Mistaken diagnoses that made an contributing delay identification disease, rheumatic fever growing pains paralysis female), chilblains erythermalgia female). In adulthood, following mistaken made: Sjogren's and/or sicca (6 females), systemic sclerosis male), dysautonomia familial Mediterranean Conclusion usually delayed, due confusion common disorders. may constitute symptoms. Past typical. Osteoporosis develop become severe. Together family history, presence lead correct prompting assays genetic testing females. often responsible for manifestations, most osteoporosis. These inaugural diagnostic wanderings. They require specific treatment strategies.

参考文章(22)
Henriette Mersebach, Jan-Ove Johansson, åse krogh Rasmussen, Bengt-Åke Bengtsson, Kirsten Rosenberg, Lis Hasholt, Sven Asger Sørensen, Søren schwartz Sørensen, Ulla Feldt-Rasmussen, Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density Genetics in Medicine. ,vol. 9, pp. 812- 818 ,(2007) , 10.1097/GIM.0B013E31815CB197
Rolando Cimaz, Severine Guillaume, Max J. Hilz, Gerd Horneff, Bernhard Manger, J. Carter Thorne, Anette Torvin Møller, Nico M. Wulffraat, Johannes Roth, Awareness of Fabry disease among rheumatologists—current status and perspectives Clinical Rheumatology. ,vol. 30, pp. 467- 475 ,(2011) , 10.1007/S10067-010-1445-Z
C. M. Eng, J. Fletcher, W. R. Wilcox, S. Waldek, C. R. Scott, D. O. Sillence, F. Breunig, J. Charrow, D. P. Germain, K. Nicholls, M. Banikazemi, Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry. Journal of Inherited Metabolic Disease. ,vol. 30, pp. 184- 192 ,(2007) , 10.1007/S10545-007-0521-2
Olivier Lidove, Michael L West, Guillem Pintos-Morell, Ricardo Reisin, Kathy Nicholls, Luis E Figuera, Rossella Parini, Luiz R Carvalho, Christoph Kampmann, Gregory M Pastores, Atul Mehta, Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature Genetics in Medicine. ,vol. 12, pp. 668- 679 ,(2010) , 10.1097/GIM.0B013E3181F13B75
Raphael Schiffmann, Jeffrey B. Kopp, Howard A. Austin III, Sharda Sabnis, David F. Moore, Thais Weibel, James E. Balow, Roscoe O. Brady, Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. ,vol. 285, pp. 2743- 2749 ,(2001) , 10.1001/JAMA.285.21.2743
Luca Padua, Costanza Pazzaglia, Emanuela Morgante, Carlos Centurion, Daniela Antuzzi, Matteo A. Russo, Andrea Frustaci, Cristina Chimenti, Cardiac and skeletal myopathy in Fabry disease: a clinicopathologic correlative study Human Pathology. ,vol. 43, pp. 1444- 1452 ,(2012) , 10.1016/J.HUMPATH.2011.09.020
William R Wilcox, João Paulo Oliveira, Robert J Hopkin, Alberto Ortiz, Maryam Banikazemi, Ulla Feldt-Rasmussen, Katherine Sims, Stephen Waldek, Gregory M Pastores, Philip Lee, Christine M Eng, Laszlo Marodi, Kevin E Stanford, Frank Breunig, Christoph Wanner, David G Warnock, Roberta M Lemay, Dominique P Germain, None, Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry Molecular Genetics and Metabolism. ,vol. 93, pp. 112- 128 ,(2008) , 10.1016/J.YMGME.2007.09.013
K Sacre, O Lidove, B Giroux Leprieur, N Ouali, J Laganier, C Caillaud, T Papo, Bone and joint involvement in Fabry disease Scandinavian Journal of Rheumatology. ,vol. 39, pp. 171- 174 ,(2010) , 10.3109/03009740903270631
Stephen Waldek, Manesh R Patel, Maryam Banikazemi, Roberta Lemay, Philip Lee, Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry Genetics in Medicine. ,vol. 11, pp. 790- 796 ,(2009) , 10.1097/GIM.0B013E3181BB05BB